VYMADA 100 MG 14 TABLETS | Sacubitril + Valsartan for Heart Failure
VYMADA 100 MG 14 TABLETS contain Sacubitril 49 mg and Valsartan 51 mg, a prescription ARNI medicine used to treat chronic heart failure and reduce the risk of hospitalization and cardiovascular death.
VYMADA 100 MG 14 TABLETS
VYMADA 100 MG 14 TABLETS (Sacubitril 49 mg + Valsartan 51 mg): Comprehensive Guide and Benefits
Introduction to VYMADA 100 MG 14 TABLETS
ARNI Therapy for Chronic Heart Failure
VYMADA 100 MG 14 TABLETS are a prescription-only medicine containing Sacubitril 49 mg and Valsartan 51 mg. This combination belongs to the class of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) and is indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). It helps improve heart function, reduce the risk of hospitalization due to heart failure, and lower the risk of cardiovascular death when used as part of a comprehensive treatment plan.
Key Benefits of VYMADA 100 MG 14 TABLETS
Helps improve heart pumping efficiency.
Reduces the risk of hospitalization due to chronic heart failure.
Lowers the risk of cardiovascular death.
Helps relieve symptoms such as breathlessness, fatigue, and swelling.
Supports improved quality of life when used alongside standard heart failure therapy.
How VYMADA 100 MG Works
VYMADA combines two medicines with complementary mechanisms:
Sacubitril inhibits the enzyme neprilysin, increasing beneficial natriuretic peptides that promote blood vessel relaxation, sodium excretion, and reduced strain on the heart.
Valsartan is an angiotensin II receptor blocker (ARB) that blocks the effects of angiotensin II, relaxing blood vessels, lowering blood pressure, and reducing the heart's workload.
Together, these actions improve heart function and slow the progression of chronic heart failure.
Usage Instructions
Take the medicine exactly as prescribed by your healthcare provider.
May be taken with or without food.
Swallow the tablet whole with water.
Take it at the same time every day.
Continue treatment regularly even if you feel well.
Do not stop taking the medicine without consulting your doctor.
Medicinal Advantages
Proven treatment for chronic heart failure with reduced ejection fraction.
Helps decrease heart failure-related hospitalizations.
Reduces cardiovascular mortality.
Combines two complementary therapies in one tablet.
Convenient oral treatment that supports guideline-directed heart failure management.
NOTE: VYMADA should not be used together with an ACE inhibitor. A washout period of at least 36 hours is required when switching from an ACE inhibitor to VYMADA to reduce the risk of angioedema.
Off-Label Uses
VYMADA should generally be used only for its approved indication in chronic heart failure unless otherwise recommended by a cardiologist.
Expert Advice
Monitor your blood pressure regularly.
Attend scheduled kidney function and potassium blood tests.
Follow a low-sodium diet if advised.
Take all prescribed heart failure medications consistently.
Seek immediate medical attention if you develop swelling of the face, lips, tongue, or difficulty breathing.
Precautions
Pregnancy & Breastfeeding
Do not use VYMADA during pregnancy, as it may cause serious harm to the unborn baby. Breastfeeding is generally not recommended unless advised by your healthcare provider.
Kidney & Liver Function
Use cautiously in patients with kidney or liver impairment. Regular monitoring of kidney function and serum potassium is recommended during treatment.
Drug Interactions
Inform your healthcare provider if you are taking:
ACE inhibitors.
Other ARBs.
Potassium supplements or potassium-sparing diuretics.
NSAIDs (such as ibuprofen or diclofenac).
Lithium.
Aliskiren.
These medicines may increase the risk of adverse effects or drug interactions.
Existing Medical Conditions
Tell your healthcare provider if you have:
Chronic heart failure.
Kidney disease.
Liver disease.
Low blood pressure.
History of angioedema.
Diabetes.
Storage Instructions
Store below 30°C.
Keep in the original blister pack.
Protect from moisture and excessive heat.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is VYMADA 100 MG used for?
A: It is used to treat chronic heart failure, helping reduce the risk of hospitalization and cardiovascular death while improving heart function.
Q: What are the active ingredients?
A: Each tablet contains Sacubitril 49 mg and Valsartan 51 mg.
Q: What are the common side effects?
A: Common side effects include low blood pressure, dizziness, cough, increased potassium levels, impaired kidney function, and fatigue.
Q: Can I take VYMADA with an ACE inhibitor?
A: No. A minimum 36-hour washout period is required between stopping an ACE inhibitor and starting VYMADA.
Q: Can I stop taking VYMADA if I feel better?
A: No. Continue taking the medicine as prescribed. Stopping treatment without medical advice may worsen heart failure.
Q: Is VYMADA available without a prescription?
A: No. VYMADA 100 MG is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Product Tags
VYMADA 100 MG 14 TABLETS, Sacubitril 49 mg, Valsartan 51 mg, Sacubitril Valsartan Tablet, ARNI Medicine, Heart Failure Treatment, Chronic Heart Failure, HFrEF Medicine, Cardiovascular Medicine, Prescription Heart Medicine, Heart Failure Therapy, Blood Pressure Medicine, Cardiac Care, Angiotensin Receptor Neprilysin Inhibitor, Heart Function Support, Novartis VYMADA, Sacubitril Valsartan 100 mg, Heart Failure Medication, Prescription Cardiovascular Tablet, Chronic Heart Failure Management.
